The seventh in Springer's landmark series of edited volumes on one of
the highest-profile subjects in contemporary medicine and scientific
endeavour, this volume sets out to cover a staggering range of research
into the medical applications of stem cell research. While stem cells
are the very stuff of life for multicellular organisms, including us
humans, the cancer stem cell is a morbid entity with a robust resistance
to therapies including conventional chemotherapy. This authoritative
publication explains the regenerative potential of stem cells and their
mesenchymal progeny, reviewing clinical applications of the latter in
the treatment of cancer, diabetes and neurodegenerative pathologies. It
covers the entire range of stem cells with known potential for
therapeutic use, from human embryonic to germ cell-derived pluripotent
stem cells and hematopoietic stem cells. The chapters also deal with the
role of TGF-beta in propagating human embryonic stem cells, and in
facilitating their differentiation. Featuring discussions of molecular
signaling pathways that modulate mesenchymal stem cell self-renewal and
much more, this book is certain to have broad appeal among academicians
and physicians alike.